thenationalherald.comFactualityFactuality is a Premium featureRightRightBased on the outlet's overall lean; article framing check pending

WASHINGTON (AP) — Popular weight loss drugs including Ozempic and Wegovy will carry a new warning about a possible rare side effect that can sometimes lead to permanent vision loss, U.S. health regulators announced Monday. The Food and Drug Administration said the risk will be added to the labeling of all GLP-1 drugs, the blockbuster... The post FDA Adds Rare Vision-Loss Warning to Popular GLP-1 Drugs appeared first on The National Herald .

2 days ago · thenationalherald.com · You are reading this one